NasdaqGS - Delayed Quote • USD
HUTCHMED (China) Limited (HCM)
At close: April 19 at 4:00 PM EDT
After hours: April 19 at 7:52 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (1970) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (1970) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | ||||
|---|---|---|---|---|
| EPS Est. | -- | -- | -- | -- |
| EPS Actual | -- | -- | -- | -- |
| Difference | -- | -- | -- | -- |
| Surprise % | -- | -- | -- | -- |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (1970) | Next Year (1970) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (1970) | Next Year (1970) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | HCM | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 1.60% |
| Next Qtr. | -- | -- | -- | 10.50% |
| Current Year | -- | -- | -- | 5.20% |
| Next Year | -- | -- | -- | 13.30% |
| Next 5 Years (per annum) | 105.40% | -- | -- | 11.22% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Upgrades & Downgrades
| Upgrade | Deutsche Bank: Hold to Buy | 11/24/2023 |
| Maintains | Goldman Sachs: Neutral to Neutral | 11/10/2023 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 9/5/2023 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 7/24/2023 |
| Maintains | Goldman Sachs: Neutral | 8/9/2022 |
| Maintains | Goldman Sachs: Neutral | 8/2/2022 |
Related Tickers
IRWD Ironwood Pharmaceuticals, Inc.
7.92
+4.21%
688192.SS Dizal (Jiangsu) Pharmaceutical Co., Ltd.
35.40
-4.71%
300558.SZ Betta Pharmaceuticals Co., Ltd.
36.04
-1.02%
FAGI Full Alliance Group, Inc.
0.0129
0.00%
INDV Indivior PLC
18.52
-1.28%
CTLT Catalent, Inc.
55.48
-0.57%
SFLM SFLMaven Corp.
0.0003
0.00%
EVO Evotec SE
7.07
-1.12%
RICH.BA Laboratorios Richmond S.A.C.I.F.
874.50
+0.17%
EXMT Anything Technologies Media, Inc.
0.0006
0.00%